Literature DB >> 4055458

125I interstitial brachytherapy for primary malignant brain tumors: technical aspects of treatment planning and implantation methods.

P A Findlay, D C Wright, U Rosenow, F S Harrington, R W Miller.   

Abstract

Use of interstitial radiation holds promise in the treatment of primary malignant brain tumors, but optimal technical factors have yet to be determined. We have developed a method of precise CT directed stereotactic placement of radioactive sources in a predetermined target volume. We use low activity (1-2 millicurie/speed) sources of 125I loaded in silastic catheters, which are positioned in a parallel array in the target. Positioning of such multiple sources toward the periphery of the volume enhances achievable dose homogeneity. Seeds of various activities can be differentially loaded into each catheter and the catheters can be positioned at various radii from the central target so that the treated volume corresponds to the identified (often irregular) target volume. Although the implant is designed to be permanent, the sources can be removed easily in a second procedure.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4055458     DOI: 10.1016/0360-3016(85)90287-1

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  3 in total

1.  Incidence of late radiation necrosis with transient mass effect after interstitial low dose rate radiotherapy for cerebral gliomas.

Authors:  B Wowra; H P Schmitt; V Sturm
Journal:  Acta Neurochir (Wien)       Date:  1989       Impact factor: 2.216

2.  Interstitial brachytherapy for low-grade cerebral gliomas: analysis of results in a series of 36 cases.

Authors:  M Scerrati; P Montemaggi; M Iacoangeli; R Roselli; G F Rossi
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

Review 3.  Back to the future--radiotherapy in high grade gliomas.

Authors:  M Brada
Journal:  Br J Cancer       Date:  1989-07       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.